InspireMD eliminated the Chief Commercial Officer position, with Shane Gleason's last day set for July 31, 2026.Original SEC Filing: InspireMD, Inc. [ NSPR ] - 8-K - Jul. 29, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Pl…
On July 17, 2026, the company received notice from Nasdaq that it failed to maintain the minimum $1.00 bid price under Listing Rule 5550(a)(2) after 30 consecutive business days below the threshold. InspireMD has 180 days, until January 13, 2027, to regain compliance, and its stock continues to tra…
InspireMD director Raymond W. Cohen resigned from the board, effective July 1, 2026, citing personal considerations.Original SEC Filing: InspireMD, Inc. [ NSPR ] - 8-K - Jul. 02, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source…
